The Multi-Omics Revolution
Currently, genomics studies contribute the vast majority of precision medicine- based data. As of August 2016, over 2,500 genome wide association studies (GWAS) have published their findings in the literature 1. And this figure is set to rise as improvements in next generation sequencing (NGS) technologies continue to reduce the cost and turnaround time per genome sequenced. Add to this the parallel leaps and bounds being made in bioinformatics and computational capacity and one essentially has the blueprints for a genomic golden era, which can only mean good things for precision medicine. However, although genomics big data offers a pretty comprehensive snapshot of what precision medicine entails at present, the discipline is set to encompasses much, much more.